A Phase II Study: CRS207/GVAX Plus Anti-PD1 and Anti-CTLA4 Recruits Mesothelin- and KRAS-Specific T cells into PDAC

dbGaP FAQdbGaP Access Request Video Tutorial

Platforms

dbGaP

View in dbGaP

phs003798.v1.p1

APIs

Consent Codes

HMB-IRB-NPU

Focus / Diseases

Pancreatic Neoplasms

Study Design

Clinical Trial

Data Types

RNA-Seq

Subjects

61